DE19929348A1 - Verfahren zur Herstellung von 2-Heterocyclylmethyl-benzoesäurederivaten - Google Patents
Verfahren zur Herstellung von 2-Heterocyclylmethyl-benzoesäurederivatenInfo
- Publication number
- DE19929348A1 DE19929348A1 DE19929348A DE19929348A DE19929348A1 DE 19929348 A1 DE19929348 A1 DE 19929348A1 DE 19929348 A DE19929348 A DE 19929348A DE 19929348 A DE19929348 A DE 19929348A DE 19929348 A1 DE19929348 A1 DE 19929348A1
- Authority
- DE
- Germany
- Prior art keywords
- halogen
- alkyl
- optionally
- optionally substituted
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/42—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/04—1,2,3-Triazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19929348A DE19929348A1 (de) | 1999-06-26 | 1999-06-26 | Verfahren zur Herstellung von 2-Heterocyclylmethyl-benzoesäurederivaten |
AU55325/00A AU5532500A (en) | 1999-06-26 | 2000-06-13 | Method for producing 2-heterocyclyl methyl benzoic acid derivatives |
BR0012451-6A BR0012451A (pt) | 1999-06-26 | 2000-06-13 | Processo para a preparação de derivados de ácido 2-heterociclilmetil-benzóico |
MXPA01013263A MXPA01013263A (es) | 1999-06-26 | 2000-06-13 | Procedimiento para la obtencion de derivados del acido 2-heterociclilmetil-benzoico. |
PCT/EP2000/005412 WO2001000595A1 (de) | 1999-06-26 | 2000-06-13 | Verfahren zur herstellung von 2-heterocyclylmethyl-benzoesäurederivaten |
JP2001507005A JP2003503396A (ja) | 1999-06-26 | 2000-06-13 | 2−ヘテロシクリルメチル安息香酸誘導体の製造方法 |
CN00809503A CN1358176A (zh) | 1999-06-26 | 2000-06-13 | 制备2-杂环基甲基苯甲酸衍生物的方法 |
EP00940367A EP1194419A1 (de) | 1999-06-26 | 2000-06-13 | Verfahren zur herstellung von 2-heterocyclylmethyl-benzoesäurederivaten |
IL14666200A IL146662A0 (en) | 1999-06-26 | 2000-06-13 | Method for producing 2-heterocyclyl methyl benzoic acid derivatives |
HK03100101.3A HK1047932A1 (zh) | 1999-06-26 | 2003-01-03 | 製備2-雜環基甲基苯甲酸衍生物的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19929348A DE19929348A1 (de) | 1999-06-26 | 1999-06-26 | Verfahren zur Herstellung von 2-Heterocyclylmethyl-benzoesäurederivaten |
Publications (1)
Publication Number | Publication Date |
---|---|
DE19929348A1 true DE19929348A1 (de) | 2000-12-28 |
Family
ID=7912666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19929348A Withdrawn DE19929348A1 (de) | 1999-06-26 | 1999-06-26 | Verfahren zur Herstellung von 2-Heterocyclylmethyl-benzoesäurederivaten |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1194419A1 (zh) |
JP (1) | JP2003503396A (zh) |
CN (1) | CN1358176A (zh) |
AU (1) | AU5532500A (zh) |
BR (1) | BR0012451A (zh) |
DE (1) | DE19929348A1 (zh) |
HK (1) | HK1047932A1 (zh) |
IL (1) | IL146662A0 (zh) |
MX (1) | MXPA01013263A (zh) |
WO (1) | WO2001000595A1 (zh) |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010063402A1 (de) * | 2008-12-06 | 2010-06-10 | Bayer Schering Pharma Aktiengesellschaft | Substituierte benzyl- und phenylsulfonyltriazolone und ihre verwendung |
US8114868B2 (en) | 2008-07-25 | 2012-02-14 | Boehringer Ingelheim International Gmbh | Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
US8138178B2 (en) | 2008-05-01 | 2012-03-20 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
US8202857B2 (en) | 2008-02-11 | 2012-06-19 | Vitae Pharmaceuticals, Inc. | 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
US8242111B2 (en) | 2008-05-01 | 2012-08-14 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
US8329897B2 (en) | 2007-07-26 | 2012-12-11 | Vitae Pharmaceuticals, Inc. | Synthesis of inhibitors of 11β-hydroxysteroid dehydrogenase type 1 |
US8440658B2 (en) | 2007-12-11 | 2013-05-14 | Vitae Pharmaceuticals, Inc. | Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
US8569292B2 (en) | 2008-05-01 | 2013-10-29 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
US8592410B2 (en) | 2008-05-01 | 2013-11-26 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11BETA-hydroxysteroid dehydrogenase 1 |
US8592409B2 (en) | 2008-01-24 | 2013-11-26 | Vitae Pharmaceuticals, Inc. | Cyclic carbazate and semicarbazide inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
US8598160B2 (en) | 2008-02-15 | 2013-12-03 | Vitae Pharmaceuticals, Inc. | Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
US8637505B2 (en) | 2009-02-04 | 2014-01-28 | Boehringer Ingelheim International Gmbh | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
US8680281B2 (en) | 2008-01-07 | 2014-03-25 | Vitae Pharmaceuticals, Inc. | Lactam inhibitors of 11-β-hydroxysteroid dehydrogenase 1 |
US8680093B2 (en) | 2009-04-30 | 2014-03-25 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
US8765744B2 (en) | 2010-06-25 | 2014-07-01 | Boehringer Ingelheim International Gmbh | Azaspirohexanones |
US8835426B2 (en) | 2007-02-26 | 2014-09-16 | Vitae Pharmaceuticals, Inc. | Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
US8846613B2 (en) | 2010-11-02 | 2014-09-30 | Boehringer Ingelheim International Gmbh | Pharmaceutical combinations for the treatment of metabolic disorders |
US8846668B2 (en) | 2008-07-25 | 2014-09-30 | Vitae Pharmaceuticals, Inc. | Inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
US8883778B2 (en) | 2009-07-01 | 2014-11-11 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1 |
US8927539B2 (en) | 2009-06-11 | 2015-01-06 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure |
US8933072B2 (en) | 2010-06-16 | 2015-01-13 | Vitae Pharmaceuticals, Inc. | Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6914082B2 (en) | 2001-12-14 | 2005-07-05 | Conocophillips Company | Slurry bubble reactor operated in well-mixed gas flow regime |
US7230035B2 (en) | 2002-12-30 | 2007-06-12 | Conocophillips Company | Catalysts for the conversion of methane to synthesis gas |
DE102006024024A1 (de) | 2006-05-23 | 2007-11-29 | Bayer Healthcare Aktiengesellschaft | Substituierte Arylimidazolone und -triazolone sowie ihre Verwendung |
DE102010001064A1 (de) | 2009-03-18 | 2010-09-23 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 2-Acetamido-5-Aryl-1,2,4-triazolone und deren Verwendung |
CA2791100C (en) | 2010-02-27 | 2018-01-30 | Bayer Intellectual Property Gmbh | Bisaryl-bonded aryltriazolones and use thereof |
DE102010040187A1 (de) | 2010-09-02 | 2012-03-08 | Bayer Schering Pharma Aktiengesellschaft | Substituierte N-Phenethyl-triazolonacetamide und ihre Verwendung |
DE102010040924A1 (de) | 2010-09-16 | 2012-03-22 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Phenylacet- und Phenylpropanamide und ihre Verwendung |
MA40893B1 (fr) | 2014-11-03 | 2018-11-30 | Bayer Pharma AG | Dérivés de phényltriazole à substitution hydroxyalkyle et utilisations associées |
US9988367B2 (en) | 2016-05-03 | 2018-06-05 | Bayer Pharma Aktiengesellschaft | Amide-substituted pyridinyltriazole derivatives and uses thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19627901A1 (de) * | 1996-07-11 | 1998-01-15 | Bayer Ag | Substituierte aromatische Carbonylverbindungen und ihre Derivate |
DE19921732A1 (de) * | 1998-07-24 | 2000-01-27 | Bayer Ag | Substituierte Benzoylcyclohexandione |
-
1999
- 1999-06-26 DE DE19929348A patent/DE19929348A1/de not_active Withdrawn
-
2000
- 2000-06-13 BR BR0012451-6A patent/BR0012451A/pt not_active Application Discontinuation
- 2000-06-13 EP EP00940367A patent/EP1194419A1/de not_active Withdrawn
- 2000-06-13 AU AU55325/00A patent/AU5532500A/en not_active Abandoned
- 2000-06-13 MX MXPA01013263A patent/MXPA01013263A/es not_active Application Discontinuation
- 2000-06-13 WO PCT/EP2000/005412 patent/WO2001000595A1/de not_active Application Discontinuation
- 2000-06-13 IL IL14666200A patent/IL146662A0/xx unknown
- 2000-06-13 JP JP2001507005A patent/JP2003503396A/ja active Pending
- 2000-06-13 CN CN00809503A patent/CN1358176A/zh active Pending
-
2003
- 2003-01-03 HK HK03100101.3A patent/HK1047932A1/zh unknown
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8835426B2 (en) | 2007-02-26 | 2014-09-16 | Vitae Pharmaceuticals, Inc. | Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
US8329897B2 (en) | 2007-07-26 | 2012-12-11 | Vitae Pharmaceuticals, Inc. | Synthesis of inhibitors of 11β-hydroxysteroid dehydrogenase type 1 |
US8575156B2 (en) | 2007-07-26 | 2013-11-05 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
US8748444B2 (en) | 2007-12-11 | 2014-06-10 | Vitae Pharmaceuticals, Inc. | Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
US8440658B2 (en) | 2007-12-11 | 2013-05-14 | Vitae Pharmaceuticals, Inc. | Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
US8680281B2 (en) | 2008-01-07 | 2014-03-25 | Vitae Pharmaceuticals, Inc. | Lactam inhibitors of 11-β-hydroxysteroid dehydrogenase 1 |
US8592409B2 (en) | 2008-01-24 | 2013-11-26 | Vitae Pharmaceuticals, Inc. | Cyclic carbazate and semicarbazide inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
US8202857B2 (en) | 2008-02-11 | 2012-06-19 | Vitae Pharmaceuticals, Inc. | 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
US8598160B2 (en) | 2008-02-15 | 2013-12-03 | Vitae Pharmaceuticals, Inc. | Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
US8242111B2 (en) | 2008-05-01 | 2012-08-14 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
US8592410B2 (en) | 2008-05-01 | 2013-11-26 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11BETA-hydroxysteroid dehydrogenase 1 |
US8569292B2 (en) | 2008-05-01 | 2013-10-29 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
US8673899B2 (en) | 2008-05-01 | 2014-03-18 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
US8138178B2 (en) | 2008-05-01 | 2012-03-20 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
US8846668B2 (en) | 2008-07-25 | 2014-09-30 | Vitae Pharmaceuticals, Inc. | Inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
US8114868B2 (en) | 2008-07-25 | 2012-02-14 | Boehringer Ingelheim International Gmbh | Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
US8754076B2 (en) | 2008-07-25 | 2014-06-17 | Vitae Pharmaceuticals, Inc./Boehringer-Ingelheim | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
WO2010063402A1 (de) * | 2008-12-06 | 2010-06-10 | Bayer Schering Pharma Aktiengesellschaft | Substituierte benzyl- und phenylsulfonyltriazolone und ihre verwendung |
US8637505B2 (en) | 2009-02-04 | 2014-01-28 | Boehringer Ingelheim International Gmbh | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
US8680093B2 (en) | 2009-04-30 | 2014-03-25 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
US8927539B2 (en) | 2009-06-11 | 2015-01-06 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure |
US8883778B2 (en) | 2009-07-01 | 2014-11-11 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1 |
US8933072B2 (en) | 2010-06-16 | 2015-01-13 | Vitae Pharmaceuticals, Inc. | Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use |
US9090605B2 (en) | 2010-06-16 | 2015-07-28 | Vitae Pharmaceuticals, Inc. | Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use |
US8765744B2 (en) | 2010-06-25 | 2014-07-01 | Boehringer Ingelheim International Gmbh | Azaspirohexanones |
US8846613B2 (en) | 2010-11-02 | 2014-09-30 | Boehringer Ingelheim International Gmbh | Pharmaceutical combinations for the treatment of metabolic disorders |
Also Published As
Publication number | Publication date |
---|---|
CN1358176A (zh) | 2002-07-10 |
WO2001000595A1 (de) | 2001-01-04 |
HK1047932A1 (zh) | 2003-03-14 |
BR0012451A (pt) | 2002-04-02 |
JP2003503396A (ja) | 2003-01-28 |
EP1194419A1 (de) | 2002-04-10 |
IL146662A0 (en) | 2002-07-25 |
AU5532500A (en) | 2001-01-31 |
MXPA01013263A (es) | 2002-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE19929348A1 (de) | Verfahren zur Herstellung von 2-Heterocyclylmethyl-benzoesäurederivaten | |
EP0399285B1 (de) | Verfahren zur Herstellung von 3-Amino-5-aminocarbonyl-1,2,4-triazol-Derivaten | |
DE10005284A1 (de) | Verfahren zur Herstellung von 1-Amino-3-aryl-uracilen | |
EP0661277B1 (de) | Verfahren und neue Zwischenprodukte zur Herstellung von Triazolinonen | |
EP0703224B1 (de) | Verfahren zur Herstellung von Alkoxytriazolinonen | |
EP0708095B1 (de) | Verfahren zur Herstellung von alkoxytriazolinonen | |
EP0659746B1 (de) | Verfahren zur Herstellung von Sulfonylaminocarbonyltriazolinonen | |
US5688963A (en) | Intermediates for the preparation of triazolinones | |
DE19610786A1 (de) | Verfahren zur Herstellung von substituierten aromatischen Thiocarbonsäureamiden | |
EP0757041A1 (de) | Verfahren zur Herstellung von substituierten Aminocarbonyltriazolinonen | |
DE10063493A1 (de) | Verfahren zur Herstellung von substituierten Arylketonen | |
DE19610785A1 (de) | Verfahren zur Herstellung von substituierten aromatischen Thiocarbonsäureamiden | |
DE69902886T2 (de) | Verfahren zur herstellung von aryloxy- oder alkoxytriazolinonen | |
EP0726259A1 (de) | Verfahren zur Herstellung von substituierten N-Carbamoyl-tetrazolinonen | |
EP0398097B1 (de) | Verfahren und neue Zwischenprodukte zur Herstellung von Triazolon-Derivaten | |
DE60005776T2 (de) | Verfahren zur Herstellung von substituierten Triazolinonen | |
US5874586A (en) | Process for preparing 1-aryl-4-carbamoyl-tetrazolinones | |
EP0764642B1 (de) | Verfahren zur Herstellung von 1-Aryl-4-carbamoyl-tetrazolinonen | |
EP0703226B1 (de) | Verfahren zur Herstellung von Alkoxytriazolinonen | |
DE3431923A1 (de) | Verfahren zur herstellung von sulvonyliso(thio)harnstoffen | |
EP0906270B1 (de) | Verfahren zur herstellung von hydroxyarenen | |
DE3920270A1 (de) | Verfahren zur herstellung von 4-amino-1,2,4-triazol-5-onen | |
EP1250318A2 (de) | Verfahren zur herstellung von aryl-iminomethyl-carbaminsäureestern | |
DE19926257A1 (de) | Verfahren zur Herstellung von Phenoxymethylpyrimidinderivaten | |
HU192897B (en) | Process for production of new derivatives of methanoazecino /5,4-b/ indole |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8139 | Disposal/non-payment of the annual fee |